A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
Clinical trial NCT06075667 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06075667
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-16
- Primary completion
- 2026-06-02
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.